A novel Reelin construct, R36, recovered behavioural deficits in the heterozygous reeler mouse

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Reelin is crucial for brain development, synaptic plasticity, learning, and memory.
• Reelin signaling pathway dysregulation is linked to neuropsychiatric disorders like schizophrenia, autism, depression, and Alzheimer's disease.
• The Reelin fragment R3456 binds ApoER2, inducing receptor clustering and signaling.

Purpose of the Study:

• To identify smaller functional fragments of Reelin's central domain.
• To investigate the biological effects of a novel Reelin fragment, R36, in vitro and in vivo.
• To assess R36's potential for therapeutic applications in Reelin-related disorders.

Main Methods:

• Utilized a luciferase complementation assay to detect ApoER2 receptor dimerization.
• Tested R36's ability to initiate intracellular signaling in primary neuronal cultures.
• Administered R36 protein via intracerebroventricular injection in heterozygous reeler mice.

Main Results:

• Identified R36 (repeats 3 and 6) as a minimal functional unit for ApoER2 dimerization.
• Demonstrated R36's capacity to trigger intracellular signaling in neurons.
• Showed that R36 injection significantly improved cognitive function in a Reelin-deficient mouse model.

Conclusions:

• The R36 construct effectively mimics Reelin's function in ApoER2 receptor dimerization and signaling.
• R36 shows therapeutic potential for enhancing the Reelin pathway.
• R36 may be a candidate for future gene therapy approaches in diseases with reduced Reelin levels.